Siblings Papers [0/1] Patents [0/11] Periodical Articles [193/194] Collection Statistics Item counts issued in 3 years:0(0.00%) Items With Fulltext:41(85.42%) Download counts of the item Download times greater than 0:41(100.00%) Download times greater than 100:41(100.00%) Total Bitstream Download Counts:24079(16.37%) Last Update: 2024-12-01 11:23 Top Upload Loading... Top Download Loading... Recent Submissions Cathepsin S inhibition alleviates o... Phase I study of biweekly liposome ... The clinical implication of O6 meth... O6BG modulates the repair activity ... Phase I dose-escalation study of so... Targeting cathepsin S induces tumor... MPT0B098, a novel microtubule inhib... Down-regulation of survivin enhance... Activation of NRF2/ABCC1 axis confe... DNA polymerase eta and a novel anti...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 26-48 of 48. (2 Page(s) Totally) << < 1 2  View [10|25|50] records per page

Date	Title	Relation
2011-09	DNA repair enzyme, O6-methylguanine DNa methyltransferase, modulates therapeutic efficacy of platinum drugs with radiation and its clinical significance	European Journal of Cancer. 2011 Sep;47:S132.
2011-07	MicroRNA signature and aberrant methylation in human oral squamous cell carcinomas	Oral Oncology. 2011 Jul;47(Suppl. 1):S92.
2011-05	Pharmacokinetic study with novel anticanacer agents, MPTOB124 and MPTOB214	Drug Metabolism Reviews. 2011 May;43(Suppl. 1):73.
2011-04	Activation of Akt/FoxO axis confers resistance to cisplatin in human nasopharyngeal carcinomas	Cancer Research. 2011 Apr;71:Abstract number 1701.
2011-04	Activation of NRF2/ABCC1 axis confers resistance to topoisomerase II poisons in human oral malignancies	Cancer Research. 2011 Apr;71:Abstract number 1528.
2011-04	MPT0B098, a novel microtubule inhibitor, displays potent anti-angiogenic activity via destabilizing hypoxia-inducible factor-1alpha mRNA	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 4461.
2011-04	Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway	Cancer Research. 2011 Apr;71(Suppl. 8):Meeting Abstract 2864.
2010-10	Combined modalities of resistance in a cisplatin-driven human betel-associated oral squamous cell carcinoma	Annals of Oncology. 2010 Oct;21(Suppl. 8):52.
2010-06	Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2010 Jun;21(Suppl. 6):27.
2009-09	Synergistic augmentation of arsenic trioxide-induced cytotoxicity by BCNU through reactive oxygen species-related autophagic pathway in human solid tumors	EJC Supplements. 2009 Sep;7(3):16.
2009-05-20	Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC)	Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587.
2009-05	Down-regulation of survivin enhances sensitivity to BPROL075 in human cancer cells via caspase-independent mechanisms	Cancer Research. 2009 May;69:Abstract number 5542.
2007-07	A novel oral indoline-sulfonamide derivative, J30, exhibits potent activity against human cancer cells both in in vitro and in vivo through disruption of microtubule	Drugs of the Future. 2007 Jul;32(Suppl. A):35-36.
2006-11	Combined modalities of resistance in an oxaliplaitin-resistant human gastric cancer cell line with enhanced sensitivity	EJC Supplements. 2006 Nov;4(12):59.
2006-11	D-501036, a novel selenophene-base triheterocycle derivative exhibits potent in vitro and in vivo anti-tumoral activity, which involves DNA-damage and ATM activation	EJC Supplements. 2006 Nov;4(12):92.
2006-11	Tamoxifen induces degradation of the o6-methylguanine DNA methyltransferase protein via the ubiquitin-dependent proteosome pathway in human cancer cells	EJC Supplements. 2006 Nov;4(12):155.
2006-02	DNA repair enzyme, O-6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors	Journal of Pharmacology and Experimental Therapeutics. 2006 Feb;316(2):946-954.
2006-01	Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma	Head and Neck. 2006 Jan;28(1):74-80.
2005-12	Induction of cell death by a novel selenophene derivative, D-501036, in human cancer cell lines	Clinical Cancer Research. 2005 Dec;11(24):9101S.
2004-09	Drug design of BPR0L075 as an anticancer agent	World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th Birthday. 2004 Sep 9-11:Abstract # 203.
2004-08-02	Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer	British Journal of Cancer. 2004 Aug;91(3):453-458.
2004-07	Drug design for BPR0L075 as an anticancer agent	Medicine in the 21st Century Tri-Conference & Bio-Forum 2004 Shanghai International Convention Center. 2004 Jul.
2002	Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma	International Journal of Cancer. 2002;Suppl. 13:336-337.

Showing items 26-48 of 48. (2 Page(s) Totally) << < 1 2  View [10|25|50] records per page